COHERUS BIOSCIENCES INC (CHRS)

US19249H1032 - Common Stock

2.27  +0.1 (+4.61%)

After market: 2.25 -0.02 (-0.88%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
326.6M
-31.36%		211M
-35.39%		257.244M
21.92%		267.15M
3.85%
EBITDA
YoY % growth
-260.4M
-263.57%		-253.2M
2.76%		N/A-5.319M
EBIT
YoY % growth
-263.9M
-268.84%		-256.9M
2.65%		-203.199M
20.90%		-73.117M
64.02%
Operating Margin
-80.80%-121.75%-78.99%-27.37%
EPS
YoY % growth
-1.15
-168.05%		-3.03
-163.48%		-2.02
33.33%		-0.59
70.66%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.25
67.12%
Revenue
Q2Q % growth		83.332M
157.20%
EBITDA
Q2Q % growth		2.04MN/AN/AN/AN/A
EBIT
Q2Q % growth		-18.391M
70.72%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.62
-3.33%		-0.12-0.50-410.06%
Q3 2023
Q2Q % growth		 -0.27
71.88%		-0.280.013.63%
Q2 2023
Q2Q % growth		 -0.38
19.15%		-0.490.1123.14%
Q1 2023
Q2Q % growth		 -0.75
25.00%		-0.58-0.17-28.45%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 91.524M
101.59%		98.328M-6.804M-6.92%
Q3 2023
Q2Q % growth		 74.6M
64.32%		84.363M-9.763M-11.57%
Q2 2023
Q2Q % growth		 58.7M
-2.49%		54.995M3.705M6.74%
Q1 2023
Q2Q % growth		 32.4M
-46.09%		48.386M-15.986M-33.04%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.02% -19.85% -135.41% -170.48%
Revenue0% -18.87% -24.5% -39.27%